GcMAF Therapy

Generally, yes. GcMAF can be safely used with a wide variety of other standard treatments and drugs to improve

GcMAF is usually combination with about 5,000 IU vitamin D3 daily. Blood levels of vitamin D are often low in

GcMAF can be safely used with a wide variety of drugs and other treatments.

Nagalase testing is not required for GcMAF therapy because macrophage activation is always necessary for the e

GcMAF and/or oral MAF immunotherapy are recommended for the management of conditions characterized by immune d

Cancer: For Second Generation GcMAF therapy we recommend 0.5 ml High Dose GcMAF (1500 ng/0.5 ml) 2-3 times a w

GcMAF administration is typically carried out through subcutaneous (SC) or intramuscular (IM) injections, with

One course of High Dose GcMAF is usually expected to be 48 doses for 6 months. Additional courses may be requi

We recommend checking tumor markers and regular MRI, PET and CT scans. Monocyte Count: A patients monocyte cou

Second Generation GcMAF has been clinically demonstrated to be largely free of any side effects in the great m